Research Roundup

OFFICIAL PUBLICATION OF

by its subsidiary APPco

Debbie Rigby 06/10/2020

Debbie Rigby rounds up the latest in research news SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials Both DAPA-HF (assessing dapagliflozin) and EMPEROR-Reduced (assessing empagliflozin) trials showed that sodium-glucose co-transporter-2 (SGLT2) inhibition reduced the combined risk of cardiovascular death or hospitalisation for heart failure

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Sigma/CWH merger to change pharmacy

Michael Nobody drafts my emails. They are my own words. Yes, so strange that your evidence couldn't be posted! Perhaps…

Anthony Tassone

Sigma/CWH merger to change pharmacy

Prefer to talk to chemist , but unwilling to pay to have that service made available. That's why chemist warehouse…

Bob Tran

Sigma/CWH merger to change pharmacy

Absolutely pathetic excuse by Wesfarmers. They're an ASX heavyweight and they're afraid of a smaller company? The lack of innovation…

Morbidly Obese John

Sigma/CWH merger to change pharmacy

You seen the average wage working for these toxic workplaces in USA? Our toxic workplaces have a lot to catch…

Philip Smith

Research Roundup

Previous Outgoing president lauded

Next Clinical tips: worms

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Outgoing president lauded

Next Clinical tips: worms

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.